Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results

Objective: The aims of this study were to compare the clinical outcomes between ultrasound-guided percutaneous microwave ablation (US-PMWA) and surgical resection (SR) in patients with recurrent intrahepatic cholangiocarcinoma (ICC) and to identify the prognostic factors associated with the two trea...

Full description

Bibliographic Details
Main Authors: Chuanjun Xu, Lei Li, Wei Xu, Chao Du, Lixin Yang, Jinlong Tong, Yongxiang Yi
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2019.1571247
_version_ 1818303479053025280
author Chuanjun Xu
Lei Li
Wei Xu
Chao Du
Lixin Yang
Jinlong Tong
Yongxiang Yi
author_facet Chuanjun Xu
Lei Li
Wei Xu
Chao Du
Lixin Yang
Jinlong Tong
Yongxiang Yi
author_sort Chuanjun Xu
collection DOAJ
description Objective: The aims of this study were to compare the clinical outcomes between ultrasound-guided percutaneous microwave ablation (US-PMWA) and surgical resection (SR) in patients with recurrent intrahepatic cholangiocarcinoma (ICC) and to identify the prognostic factors associated with the two treatment methods. Methods: This retrospective study was institutional review board approved. A total of 121 patients (102 men and 19 women) with 136 ICCs after hepatectomy from April 2011 to January 2017 were reviewed. Fifty-six patients underwent US-PMWA and 65 patients underwent SR. Survival, recurrence and liver function were compared between the two groups. Effect of changes in key parameters [i.e., overall survival (OS) and recurrence-free survival (RFS)] was statistically analyzed with the log-rank test. Univariate and multivariate analysis were performed on clinicopathological variables to identify factors affecting long-term outcome. Results: The OS and RFS after MWA were comparable to that of SR (p = .405, and p = .589, respectively). Estimated 5-year OS rates were 23.7% after MWA and 21.8% after SR; for RFS, estimated 3-year RFS rates were 33.1% after MWA and 30.6% after SR. Major complication rates in SR group were higher than that in MWA (p < .001) (SR, 13.8% vs. MWA, 5.3%). Multivariate analysis showed tumor number (p = .012), ALBI grade (p = .007), and metastasis (p = .016), may become OS rate predictors. Conclusions: US-PMWA had comparable oncologic outcomes with SR and could be a safe and effective treatment for recurrent ICC after hepatectomy.
first_indexed 2024-12-13T05:55:27Z
format Article
id doaj.art-75cbd3ab8ee14578b580f73da68a4aca
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-12-13T05:55:27Z
publishDate 2019-01-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-75cbd3ab8ee14578b580f73da68a4aca2022-12-21T23:57:26ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572019-01-0136135035710.1080/02656736.2019.15712471571247Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term resultsChuanjun Xu0Lei Li1Wei Xu2Chao Du3Lixin Yang4Jinlong Tong5Yongxiang Yi6The Second Hospital of Nanjing Nanjing University of Chinese MedicineThe Affiliated Central Hospital of Qingdao UniversityThe Affiliated Central Hospital of Qingdao UniversityThe Second Hospital of Nanjing Nanjing University of Chinese MedicineThe Second Hospital of Nanjing Nanjing University of Chinese MedicineThe Second Hospital of Nanjing Nanjing University of Chinese MedicineThe Second Hospital of Nanjing Nanjing University of Chinese MedicineObjective: The aims of this study were to compare the clinical outcomes between ultrasound-guided percutaneous microwave ablation (US-PMWA) and surgical resection (SR) in patients with recurrent intrahepatic cholangiocarcinoma (ICC) and to identify the prognostic factors associated with the two treatment methods. Methods: This retrospective study was institutional review board approved. A total of 121 patients (102 men and 19 women) with 136 ICCs after hepatectomy from April 2011 to January 2017 were reviewed. Fifty-six patients underwent US-PMWA and 65 patients underwent SR. Survival, recurrence and liver function were compared between the two groups. Effect of changes in key parameters [i.e., overall survival (OS) and recurrence-free survival (RFS)] was statistically analyzed with the log-rank test. Univariate and multivariate analysis were performed on clinicopathological variables to identify factors affecting long-term outcome. Results: The OS and RFS after MWA were comparable to that of SR (p = .405, and p = .589, respectively). Estimated 5-year OS rates were 23.7% after MWA and 21.8% after SR; for RFS, estimated 3-year RFS rates were 33.1% after MWA and 30.6% after SR. Major complication rates in SR group were higher than that in MWA (p < .001) (SR, 13.8% vs. MWA, 5.3%). Multivariate analysis showed tumor number (p = .012), ALBI grade (p = .007), and metastasis (p = .016), may become OS rate predictors. Conclusions: US-PMWA had comparable oncologic outcomes with SR and could be a safe and effective treatment for recurrent ICC after hepatectomy.http://dx.doi.org/10.1080/02656736.2019.1571247intrahepatic cholangiocarcinomamicrowave ablationsurgical resectionpercutaneousultrasound-guided
spellingShingle Chuanjun Xu
Lei Li
Wei Xu
Chao Du
Lixin Yang
Jinlong Tong
Yongxiang Yi
Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
International Journal of Hyperthermia
intrahepatic cholangiocarcinoma
microwave ablation
surgical resection
percutaneous
ultrasound-guided
title Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
title_full Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
title_fullStr Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
title_full_unstemmed Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
title_short Ultrasound-guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma: intermediate-term results
title_sort ultrasound guided percutaneous microwave ablation versus surgical resection for recurrent intrahepatic cholangiocarcinoma intermediate term results
topic intrahepatic cholangiocarcinoma
microwave ablation
surgical resection
percutaneous
ultrasound-guided
url http://dx.doi.org/10.1080/02656736.2019.1571247
work_keys_str_mv AT chuanjunxu ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT leili ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT weixu ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT chaodu ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT lixinyang ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT jinlongtong ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults
AT yongxiangyi ultrasoundguidedpercutaneousmicrowaveablationversussurgicalresectionforrecurrentintrahepaticcholangiocarcinomaintermediatetermresults